retatrutide peptide dosing Dosage Guide 2026: Phase 3 TRIUMPH Data A Clinician's Guide to Retatrutide

GLP-1 agonists segment further subsegmented into Semaglutide, Liraglutide, Tirzepatide

When evaluating a patient for DGp, it is important to tease out various upper, and lower GI symptoms with a detailed medical history and to exclude other common diseases with similar manifestations

While skin irritation is not listed as a primary side effect in most clinical trials, patient reports and dermatological literature suggest a subset of users experience increased skin reactivity, dryness, or localized inflammation

Among these, the gastrointestinal mucosa harbors the most extensive immune network, continuously engaging with commensal microbes to regulate immune homeostasis [38]

[DOI] [PubMed] [Google Scholar] 18.Laurent C.M., Green J.M., Bishop P.A., Sjkvist J., Schumacker R.E., Richardson M.T., Curtner-Smith M